A New Way to Detect Patients Who Don’t Take Their Meds

Exploratory assay that measures drug concentration provides comprehensive medication monitoring.

New Anti-VEGF Delivery Method Reduces Treatment Burden

Study: 80% of AMD patients required no additional therapy for six months.

Are Meds a Culprit for Uveitis?

Review points to link, especially with newer drugs.

Neurotrophic Keratitis Finally Gets a Therapy

The first drug to treat this condition demonstrated healing in 70% of patients.

New Topical Steroid Hits the Market

Inveltys offers BID dosing and a higher concentration.

White: Not Just for Brides

The FDA recently approved a new over-the-counter alpha-adrenergic receptor agonist designed to clear your patients’ red eyes.

Migraine Sufferers May Get Relief from Glaucoma Drops

Quick-acting timolol takes effect in 15 minutes.

Anticholinergic Drugs Increase AMD Risk

New data suggests a dose-dependent association for a wide swath of medications.

Large Study Confirms Topical Glaucoma Meds, CME Association

Mainstay drugs trigger inflammatory mediators that lead to edema.

Visual Gains Lost After AMD Trial

Positive study results fail to translate into the real-world outcomes as AMD patients become less careful about their follow-up care.

Upcoming Events

December 14-15, 2018

West Coast Optometric Glaucoma Symposium
 Monarch Hotel, Dana Point, CA
Program Chairs: Murray Fingeret, OD, and Robert N. Weinreb, OD
Up to 12 CE credits (COPE approved)
Register here

February 15-19, 2019

Annual Winter Ophthalmic Conference
Location: The Westin Snowmass Conference Hotel
Program Chairs: Murray Fingeret, OD, and Leo Semes, OD
Up to 20 CE credits (COPE approval pending)
Register here


March 7-10, 2019

New Technologies & Treatments in Eye Care—Orlando, FL
Location: Disney’s Yacht & Beach Club
Program Chair: Paul Karpecki, OD, FAAO
Up to 20 CE credits (COPE approval pending)
Register here


Jobs Powered By Local Eye Site